Clinical Study
Prevalence and Predictors of Urinary Tract Infections among Children with Cerebral Palsy in Makurdi, Nigeria
Table 3
Urinary culture and sensitivity patterns among subjects with cerebral palsy and controls without cerebral palsy.
| | CP | NO CP | E. coli | Strept. faecalis | Staph. aureus | Proteus spp. | Klebsiella spp. | E. coli |
| No. of Significant growth | 9 | 4 | 3 | 2 | 2 | 2 |
| Sensitivity | | | | | | | Ciprofloxacin | 9 (100%) | 4 (100%) | 3 (100%) | 2 (100%) | 2 (100%) | 2 (100%) | Ofloxacin | 9 (100%) | 4 (100%) | 3 (100%) | 2 (100%) | 2 (100%) | 2 (100%) | Sparfloxacin | 9 (100%) | 4 (100%) | 3 (100%) | 2 (100%) | 2 (100%) | 2 (100%) | Ceftriazone | 9 (100%) | 4 (100%) | 3 (100%) | 2 (100%) | 2 (100%) | 2 (100%) | Gentamycin | 6 (66.7%) | 4 (75%) | 1 (33.3%) | 1 (50%) | 1 (50%) | 1 (50%) | Nalidixic acid | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | Streptomycin | 5 (55.6%) | 2 (50%) | 1 (33.3%) | 1 (50%) | 1 (50%) | 1 (50%) | Amoxiclav | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | Tetracycline | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | Cotrimoxazole | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | Nitrofuratoin | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
|
|
CP: Subjects with cerebral palsy, NO CP: Controls without cerebral palsy, E. coli: Escherichia coli, Staph. aureus: Staphylococcus aureus, Strept. faecalis: Streptococcus faecalis.
|